Longterm Outcome After Ventricular Septal Defect Closure

Status Completed

Clinical Trial Summary

Isolated ventricular septal defect (VSD) is a well know congenital heart anomaly. If discovered in infancy or early childhood surgical intervention can be of necessity depending on the size of the defect, to assure a healthy adulthood. The long-term results of surgical closure of VSD in childhood are good and after surgery the children are considered as equally healthy and physically fit as their peers. However, there is inconsistency in data regarding follow-up on this group of patients, in relation to exercise capacity as a measure of the cardiopulmonary function. To further approach this matter the post-operative cardiac factors of these patients have to be investigated.

With this study the investigators intend to examine the long-term outcome on cardiac output after heart surgery in VSD-patients. It presents an opportunity to also evaluate the correlation between cardiac output determined by gas-exchange and by MRI. The overall objectives of this study are to 1) examine whether VSD-operated patients have reduced cardiac output during exercise in comparison with matched controls, and furthermore 2) to evaluate a correlation between cardiac output measured by MRI and cardiac output determined by gas-exchange.

The project is designed as a long-term follow-up and method study. A cohort of 20 children who in the 1990's underwent surgical closure of a congenital VSD will be asked to participate in this study. An equal amount of healthy young adults, will function as control group. Each participant will complete two different exercise tests, a MRI of the heart during lower body exercise on a supine ergometer bicycle, and a Supine ergometer bicycle exercise test. This data can be used for comparing cardiac output between the test groups, and furthermore it allows an evaluation of the correlation between the two methods.

VSD is as described, the most common congenital heart anomaly. If not intervened with in childhood, it can cause severe heart complications later in life. It is unclear whether this intervention can cause long-term impact on patients exercise capacity, and for that reason it is of great importance that we strive for improving our knowledge of the long-term postsurgical outcome after VSD-closure.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Heart Septal Defects
Heart Septal Defects, Ventricular
Ventricular Septal Defect

Clinical Trial Details

NCT number	NCT02138435
Study type	Observational
Source	University of Aarhus
Contact
Status	Completed
Phase	N/A
Start date	March 2014
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03684161` - Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
Completed	`NCT01120964` - Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol	Phase 1/Phase 2
Completed	`NCT02914652` - The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.	Phase 4
Recruiting	`NCT05939713` - Cera™ VSD Occluder Post Market Clinical Follow-up
Recruiting	`NCT06298344` - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease	Early Phase 1
Recruiting	`NCT05688670` - Regional Anesthesia Following Pediatric Cardiac Surgery	Phase 4
Recruiting	`NCT05253209` - A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects	Phase 3
Completed	`NCT00556361` - Use of Ketamine Prior to Cardiopulmonary Bypass in Children	Phase 2
Completed	`NCT05200910` - The Effect of Transcatheter VSD Closure on Children's Appetite, Hormones and Growth
Recruiting	`NCT03127748` - Cardiac Function After Transcatheter VSD Closure	N/A
Enrolling by invitation	`NCT06214182` - Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
Active, not recruiting	`NCT04667455` - Improving Care for Children With Congenital Heart Disease.	N/A
Completed	`NCT04417712` - Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
Completed	`NCT01313832` - The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension	N/A
Active, not recruiting	`NCT04017975` - Optical Tissue Identification for Myocardial Architecture	Phase 2
Completed	`NCT01915277` - A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics	Phase 1
Recruiting	`NCT03941691` - A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure	N/A
Completed	`NCT04859036` - The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.